The claims focus on support for immune and digestive health.
Cargill (Minneapolis) announced that Health Canada has licensed 10 health claims for the company’s EpiCor postbiotic ingredient as a Natural Health Product. The health claims focus on support for immune and digestive health.
The claims are based on a daily EpiCor dose of 500 mg in adults aged 18 and older and are backed by more than a dozen published clinical studies, the company says. The claims include:
In a press release, Justin Green, PhD, director of scientific affairs for EpiCor, added, “This news, from one of the world’s leading health agencies, affirms the significant body of science behind EpiCor…”
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
May 14th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.